Arkolith/Insider Trading/SCPS/Form 4

Lamstein Joshua R

Chairman, Director, 10% OwnerScopus BioPharma Inc. (SCPS) · full profile →Form 4 · filed Aug 27, 2021
Net Buying
Open-Market Buys
$2K
Open-Market Sells
$0
Net Open-Market Flow
$2K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 27, 2021Buy(P)200$5.00$1K120K
Aug 26, 2021Buy(P)200$4.90$980120K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-21-110652) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML